Skip to main content

Latest Reports

Tradeline's industry reports are a must-read resource for those involved in facilities planning and management. Reports include management case studies, current and in-depth project profiles, and editorials on the latest facilities management issues.

Revolutionizing Veterinary Diagnostic Laboratory Design through Modern Design Principles

Published 1/20/2021

The needs and architectural considerations for a veterinary diagnostic laboratory (VDL) have evolved toward a greater focus on the value of human-centered design. At its core, the VDL’s purpose to provide diagnostic testing for infectious animal diseases remains the same: Biosafety and biosecurity are a top priority, while designs have evolved to meet today’s demands and anticipated future technological advancements. However, the visionary and technological advancements of recent decades have also resulted in an increased focus on designing with efficiency and quality of workplace in mind.

Read More

Top 10 Reports of 2020

Published 1/6/2021

The most-read Tradeline articles in 2020 reflect how the industry has responded to the COVID-19 crisis with flexibility and adaptability. From virtual site visits and virus-mitigating HVAC solutions to forward-looking models for office work, research programs, and higher education, readers learned about the innovative solutions that peer organizations have adopted to weather the storm and position themselves to thrive in the recovery.

Read More

The Big Pivot to Science Facilities

Published 12/16/2020

The life sciences industry has become the great hope in real estate, as we face the most significant public health crisis in a century. While other industries have slowed and suffered as a result of sheltering in place and working from home, science facilities have remained operational and even have thrived in prime markets, as the industry continues to search for medical breakthroughs. The downturn in other industries has left buildings vacant. The life science market, on the other hand, continues to experience some of the lowest vacancy and highest employment rates. For life science organizations in the prime U.S. markets, there simply remains a shortage of available research-capable space. Enter the big pivot to science.

Read More

Mass Timber Moves Mainstream

Published 12/2/2020

Efforts to make mass timber construction a viable alternative to concrete and steel took a giant step forward last year when Walmart announced that the 2.4 million sf of office buildings on its new Bentonville, Ark., headquarters campus would use a structural system of cross-laminated timber manufactured from regionally harvested southern yellow pine. It’s not just in the office environment where wood is becoming a contender. “We see increasing interest in using mass timber structures for research/lab buildings, especially at universities that are in major timber-producing regions,” says John Starr, a principal at Lord Aeck Sargent, a Katerra Company (LAS). Starr cited facilities at Georgia Tech, Oregon State, and Michigan State as examples.

Read More

The Evolving Role of Biocontainment Facilities in Response to COVID-19

Published 11/11/2020

The unprecedented health and economic impact of the COVID-19 pandemic is driving many institutions to increase investment in new biocontainment facilities or rapidly pivot to upgrade and repurpose existing containment spaces in an urgent attempt to respond to the crisis. Hundreds of organizations nationwide began applying for grants after the National Institutes for Health (NIH) received $3.6 billion in funding dedicated to COVID-19 research as part of an emergency stimulus bill passed earlier this year. The NIH now has until 2024 to release the funds. Additionally, private donors, non-governmental organizations, and other entities worldwide are providing billions in funding for development of testing and vaccine programs. This surge of financing is expected to fuel a growth in the creation of new biocontainment spaces in the near future and long term. Since designing, building, and commissioning new biocontainment labs is an expensive and time-consuming process, some institutions are electing to upgrade existing BSL-2 facilities to make them BSL-3, while others are choosing to move existing research programs to make room for new pandemic-related initiatives.

Read More